Search results for "Complement C1 Inhibitor Protein"

showing 5 items of 45 documents

Hereditary Angioedema: Increased Number of Attacks after Frequent Treatments with C1 Inhibitor Concentrate

2009

OBJECTIVE: C1 inhibitor concentrate is regarded as effective and safe in treating acute attacks of hereditary angioedema caused by C1 inhibitor deficiency. This study investigated the course of disease in 3 women treated frequently with C1 inhibitor concentrate. METHODS: Three women are described who received C1 inhibitor concentrate for the treatment of acute attacks of hereditary angioedema and experienced an increase in the frequency of attacks during that treatment period. In a control group of 24 patients aged more than 60 years with hereditary angioedema, the natural course of disease was determined. RESULTS: The 3 women (ages 50, 69, and 72 years) had received C1 inhibitor concentrat…

medicine.medical_specialtyAllergyPediatricsC1 inhibitor deficiencyDiseaseC1-inhibitorRecurrenceImmunopathologyHumansMedicineAgedNatural coursebiologybusiness.industryAngioedemas HereditaryGeneral MedicineMiddle Agedmedicine.diseaseTreatment periodSurgeryAcute DiseaseHereditary angioedemabiology.proteinFemalebusinessComplement C1 Inhibitor ProteinThe American Journal of Medicine
researchProduct

Hereditary angioedema: an update on causes, manifestations and treatment.

2019

Hereditary angioedema is a rare genetic disorder caused by deficiency of C1 esterase inhibitor (C1-INH) and characterized by recurrent episodes of severe swelling that affect the limbs, face, intestinal tract and airway. Since laryngeal oedema can be life-threatening as a result of asphyxiation, correct diagnosis and management of hereditary angioedema is vital. Hereditary angioedema attacks are mediated by bradykinin, the production of which is regulated by C1-INH. Hereditary angioedema therapy relies on treatment of acute attacks, and short- and long-term prophylaxis. Acute treatment options include C1-INH concentrate, icatibant and ecallantide. Self-administration of treatment is recomm…

medicine.medical_specialtyBradykinin03 medical and health sciences0302 clinical medicineimmune system diseasesmedicineHumanscardiovascular diseases030212 general & internal medicineskin and connective tissue diseasesHereditary Angioedema Types I and IIbusiness.industryGenetic disorderfood and beveragesGeneral Medicinemedicine.diseaseDermatologyC1 esterase030228 respiratory systemHereditary angioedemaFactor XIIDisease ProgressionQuality of LifeKallikreinsbusinessPeptidesComplement C1 Inhibitor ProteinBritish journal of hospital medicine (London, England : 2005)
researchProduct

Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary ang…

2013

Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of t…

medicine.medical_specialtyCanadaImmunologyMEDLINESelf AdministrationQuality of life (healthcare)Patient Education as TopicIntervention (counseling)Surveys and QuestionnairesmedicineImmunology and AllergyHumansProduct (category theory)business.industryAngioedemas HereditaryGeneral Medicinemedicine.diseaseUnited StatesEuropeCurrent practiceFamily medicineImmunologyHereditary angioedemaPhysical therapybusinessComplement C1 Inhibitor Protein
researchProduct

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.

2016

Abstract Background Hereditary angioedema (HAE) is a rare disease characterized by C1-esterase inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema, which can be life-threatening if they occur in the upper airway. No head-to-head comparisons of different treatment options for acute HAE attacks are available. Because immediate symptom relief is critical for potentially life-threatening laryngeal attacks, it is important to determine the treatment option that provides optimal treatment response. Objective Review and compare data from clinical studies that evaluated the efficacy and safety of treatments for laryngeal HAE attacks. Methods We conducted an indirect comparis…

medicine.medical_specialtyPathologyefficacyLaryngeal Diseases03 medical and health sciencesEcallantidechemistry.chemical_compound0302 clinical medicineSymptom reliefIcatibantInternal medicinemedicineHumans030212 general & internal medicineProspective cohort studyC1 esterase inhibitor deficiencybusiness.industryHAEAngioedemas Hereditarymedicine.diseaselaryngealTreatment Outcome030228 respiratory systemchemistryHereditary angioedemaEmergency MedicineC1-INHre-dosingbusinessAirwayComplement C1 Inhibitor Proteinmedicine.drugRare diseaseThe Journal of emergency medicine
researchProduct

The influence of the C1-inhibitor BERINERT® and the protein-free haemodialysate ACTIHAEMYL20%® on the evolution of the depth of scald burns in a porc…

1997

Standardized deep partial-thickness burns were inflicted on domestic pigs by scalding 30 per cent of the skin surface for 25 s with 75 degrees C hot water. The animals (n = 18; weight 25-35 kg) were divided into three groups: I, control group (n = 6), Ringer's lactate only; II, haemodialysate group (n = 6), Ringer's lactate and a protein-free haemodialysate of calf-blood (ACTIHAEMYL20%; AH) and III, C1-inhibitor group (n = 6), Ringer's lactate and C1-inhibitor (C1-INH; BERINERT). Skin biopsies were taken at defined time points (4, 28, 52 and 76 h) and investigated histologically. Depth of burn was determined morphometrically after coloration with a modified MTT-staining on frozen sections o…

medicine.medical_specialtySwineComplement C1 Inactivator ProteinsCritical Care and Intensive Care MedicineStatistics NonparametricMicrocirculationC1-inhibitorRandom AllocationReference ValuesBiopsySkin surfacemedicineScaldingAnimalsSkinWound Healingmedicine.diagnostic_testbiologybusiness.industryBiopsy NeedleHistologyGeneral Medicinemedicine.diseaseSurgeryDisease Models AnimalProtein freeAnesthesiaDisease ProgressionEmergency Medicinebiology.proteinActihaemylSurgeryBurnsWound healingbusinessComplement C1 Inhibitor ProteinBurns
researchProduct